Literature DB >> 31647554

Sea Change: A Decade of Intensity-Modulated Radiation Therapy for Treatment of Breast Cancer.

Grace L Smith1, Benjamin D Smith1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31647554      PMCID： PMC7073928          DOI： 10.1093/jnci/djz199

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  15 in total

1.  The sources of the SGR "hole".

Authors:  Ali Alhassani; Amitabh Chandra; Michael E Chernew
Journal:  N Engl J Med       Date:  2011-12-21       Impact factor: 91.245

2.  Adoption of Radiation Technology Among Privately Insured Nonelderly Patients With Cancer in the United States, 2008 to 2014: A Claims-Based Analysis.

Authors:  Hubert Y Pan; Jing Jiang; Ya-Chen Tina Shih; Benjamin D Smith
Journal:  J Am Coll Radiol       Date:  2017-04-10       Impact factor: 5.532

3.  Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy.

Authors:  Lisa A Kachnic; Henry K Tsai; John J Coen; Lawrence S Blaszkowsky; Kevan Hartshorn; Eunice L Kwak; John D Willins; David P Ryan; Theodore S Hong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-11-20       Impact factor: 7.038

4.  IMRT for breast cancer--balancing outcomes, patient selection, and resource utilization.

Authors:  Lisa A Kachnic; Simon N Powell
Journal:  J Natl Cancer Inst       Date:  2011-04-27       Impact factor: 13.506

5.  Provider variability in intensity modulated radiation therapy utilization among Medicare beneficiaries in the United States.

Authors:  Stephen R Grant; Benjamin D Smith; Anna O Likhacheva; Shervin M Shirvani; David B Rosen; B Ashleigh Guadagnolo; Dean A Shumway; Emma B Holliday; Daniel Chamberlain; Gary V Walker
Journal:  Pract Radiat Oncol       Date:  2018-02-16

6.  Intensity-Modulated Radiation Therapy in Breast Cancer Patients Following the Release of a Choosing Wisely Recommendation.

Authors:  Mylin A Torres; Keerthi Gogineni; David H Howard
Journal:  J Natl Cancer Inst       Date:  2020-03-01       Impact factor: 13.506

7.  Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203.

Authors:  Ann H Klopp; Anamaria R Yeung; Snehal Deshmukh; Karen M Gil; Lari Wenzel; Shannon N Westin; Kent Gifford; David K Gaffney; William Small; Spencer Thompson; Desiree E Doncals; Guilherme H C Cantuaria; Brian P Yaremko; Amy Chang; Vijayananda Kundapur; Dasarahally S Mohan; Michael L Haas; Yong Bae Kim; Catherine L Ferguson; Stephanie L Pugh; Lisa A Kachnic; Deborah W Bruner
Journal:  J Clin Oncol       Date:  2018-07-10       Impact factor: 44.544

8.  Adoption of intensity-modulated radiation therapy for breast cancer in the United States.

Authors:  Benjamin D Smith; I-Wen Pan; Ya-Chen T Shih; Grace L Smith; Jay R Harris; Rinaa Punglia; Lori J Pierce; Reshma Jagsi; James A Hayman; Sharon H Giordano; Thomas A Buchholz
Journal:  J Natl Cancer Inst       Date:  2011-04-27       Impact factor: 13.506

9.  Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.

Authors:  Christopher M Nutting; James P Morden; Kevin J Harrington; Teresa Guerrero Urbano; Shreerang A Bhide; Catharine Clark; Elizabeth A Miles; Aisha B Miah; Kate Newbold; MaryAnne Tanay; Fawzi Adab; Sarah J Jefferies; Christopher Scrase; Beng K Yap; Roger P A'Hern; Mark A Sydenham; Marie Emson; Emma Hall
Journal:  Lancet Oncol       Date:  2011-01-12       Impact factor: 41.316

10.  Reimbursement and use of intensity-modulated radiation therapy for prostate cancer.

Authors:  Vahakn B Shahinian; Samuel R Kaufman; Phyllis Yan; Lindsey A Herrel; Tudor Borza; Brent K Hollenbeck
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.